Rigel Pharmaceuticals, Inc. (RIGL)
47.99
+1.88
(+4.08%)
USD |
NASDAQ |
Oct 07, 16:00
47.97
-0.02
(-0.04%)
After-Hours: 20:00
Rigel Pharmaceuticals Profit Margin (Quarterly) : 21.97% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 21.97% |
| March 31, 2026 | 14.71% |
| December 31, 2025 | |
| September 30, 2025 | 40.17% |
| June 30, 2025 | 58.63% |
| March 31, 2025 | 21.46% |
| December 31, 2024 | 24.90% |
| September 30, 2024 | 22.46% |
| June 30, 2024 | -2.80% |
| March 31, 2024 | -27.92% |
| December 31, 2023 | 2.06% |
| September 30, 2023 | -20.23% |
| June 30, 2023 | -24.55% |
| March 31, 2023 | -51.92% |
| December 31, 2022 | 2.73% |
| September 30, 2022 | -84.95% |
| June 30, 2022 | -45.25% |
| March 31, 2022 | -164.0% |
| December 31, 2021 | -110.9% |
| September 30, 2021 | -97.26% |
| June 30, 2021 | -52.62% |
| March 31, 2021 | 48.75% |
| December 31, 2020 | -104.3% |
| September 30, 2020 | -77.08% |
| June 30, 2020 | -109.7% |
| Date | Value |
|---|---|
| March 31, 2020 | 38.10% |
| December 31, 2019 | -111.7% |
| September 30, 2019 | -55.09% |
| June 30, 2019 | -198.0% |
| March 31, 2019 | -139.4% |
| December 31, 2018 | 8.53% |
| September 30, 2018 | -488.5% |
| June 30, 2018 | -1.43K% |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | -1.96K% |
| June 30, 2017 | |
| March 31, 2017 | -427.3% |
| December 31, 2016 | -519.7% |
| September 30, 2016 | -601.8% |
| June 30, 2016 | -157.5% |
| March 31, 2016 | -347.3% |
| December 31, 2015 | -148.6% |
| September 30, 2015 | -51.34% |
| June 30, 2015 | -268.4% |
| March 31, 2015 | -835.3% |
| December 31, 2014 | -270.0% |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Cytokinetics, Inc. | -694.4% |
| Ironwood Pharmaceuticals, Inc. | 45.37% |
| Capricor Therapeutics, Inc. | -- |
| ACADIA Pharmaceuticals, Inc. | 10.23% |
| Alnylam Pharmaceuticals, Inc. | 12.74% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 113.6% |
| Return on Assets | 79.07% |
| Return on Invested Capital | 95.96% |
| Gross Profit Margin (Quarterly) | 89.17% |
| Operating Margin (Quarterly) | 29.95% |
| Return on Net Operating Assets | 299.6% |